Financial Reimbursement Program for Cancer Clinical Trials
This study is looking at a Financial Reimbursement Program to help people with cancer who are considering joining a clinical trial. The program aims to make it easier for patients to participate by addressing financial concerns. Researchers want to see if this program helps more people join and stay in cancer clinical trials, and they are also interested in understanding who participates and what helps or hinders their involvement. You would be asked to complete two surveys and potentially participate in follow-up interviews. The study is open to patients with any type of cancer who are eligible for a therapeutic cancer clinical trial and speak English or Spanish.
- Study design
- This is an observational study involving 1200 participants. It uses surveys and interviews to understand the impact of a financial reimbursement program.
- What's involved
- You would complete two surveys, each taking about 10-15 minutes. Some participants may also be invited for follow-up interviews after 21 days and between 30 and 90 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your clinical trial enrollment retention rate and sociodemographic characteristics will be measured for up to 60 days after enrolling in a therapeutic cancer trial.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Cancer Clinical Trials Financial Reimbursement Program
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- David E Gerber, MD · PRINCIPAL_INVESTIGATOR · Professor
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Clinical trial enrollment retention rate measured by COST PROMUp to first 60 days after enrollment to a therapeutic cancer trial.
Use COST PROM to calculate the clinical trial enrollment and retention rates of the patients eligible for and participate in the Financial Reimbursement Program (FRP) versus those that decline to participate in the FRP.
- Clinical trial enrollment retention rate measured by SAHLUp to first 60 days after enrollment to a therapeutic cancer trial.
Use SAHL to calculate the clinical trial enrollment and retention rates of the patients eligible for and participate in the Financial Reimbursement Program (FRP) versus those that decline to participate in the FRP.
- Sociodemographic characteristics of the patients measured by COST PROMUp to first 60 days after enrollment to a therapeutic cancer trial.
Use COST PROM to determine the sociodemographic characteristics of the patients eligible for and participate in the Financial Reimbursement Program (FRP) versus those that decline to participate in the FRP.
- Sociodemographic characteristics of the patients measured by SAHLUp to first 60 days after enrollment to a therapeutic cancer trial.
Use SAHL to determine the sociodemographic characteristics of the patients eligible for and participate in the Financial Reimbursement Program (FRP) versus those that decline to participate in the FRP.
- Characteristics of patients enrolled in a Financial Reimbursement Program who do versus do not submit expense documentation for reimbursementUp to first 60 days after enrollment to a therapeutic cancer trial.
The Financial Reimbursement Program will provide monthly de-identified reports to the Project team on reimbursed expenses by category, and total dollars reimbursed, stratified by study participation. Categories of financial needs/expenses are hotels, flights, parking, gas, tolls, travel companion, bus, subway, taxi/ride hailing app, car/boat service, childcare, internet access, and miscellaneous.
- Identify impact of participation in a Financial Reimbursement ProgramUp to first 60 days after enrollment to a therapeutic cancer trial.
Use COST PROM questionnaires to determine factors affecting patient participation decisions .